Search

everythinglearnresearchcommunity

for

Search:↓

New alopecia treatments aim for better results and fewer side effects.

The research suggests that the global distribution of PCOS is likely due to historical human migration and that genes affecting PCOS may have different impacts on males and females.

Seborrhea in Parkinson's disease may be linked to hormones, not autonomic impairment.

FAGA diagnosis uses blood tests and trichoscopy, with treatments like topical minoxidil, oral anti-androgens, and hormone-modulating drugs.

Lifestyle changes are the main treatment for PCOS, which is a complex condition requiring early management to reduce its health impacts.

Certain metabolites are lower in women with PCOS and could be potential markers for the condition.

Treat hair loss with finasteride, minoxidil, or surgery; consider side effects and severity.

Cyclophosphamide has serious side effects, but long-term follow-up can help manage risks.

The document suggests that clinical trials for PCOS should focus on meaningful primary outcomes like live birth rates, rather than less reliable surrogate markers.

About 3% of high school girls aged 14-18 in Isfahan, Iran, have polycystic ovary syndrome.

Hair problems are common and distressing for women, but increasing knowledge of treatments offers hope.

Women with PCOS are more likely to have fatty liver disease and worse metabolic health.

The exact cause of increased 5α-reductase activity leading to hirsutism in women is still unknown.

Epilepsy and certain epilepsy drugs can lead to reproductive problems in women, but changing medication might improve these issues.

Women with severe types of PCOS are more likely to have metabolic syndrome, and belly fat is a key predictor of this risk.

Women with female pattern hair loss have higher levels of certain androgens, suggesting increased androgen exposure to hair follicles.

Young women with PCOS have a higher risk of high blood pressure and metabolic syndrome, but these risks may decrease after age 40.

Continuous light exposure in rats leads to PCOS-like symptoms and suggests sleep habits might affect the disorder's development.

The document concludes that managing hirsutism involves identifying the cause, using a scoring system for severity, combining cosmetic and medical treatments, encouraging weight loss, and providing psychological support, while noting the need for more research on drug treatments.

Intermittent low-dose finasteride works as well as daily use for treating excessive hair growth in women.

The VEGF +405G allele may increase the risk of PCOS in South Indian women.

There is no significant link between male pattern baldness and insulin resistance.

The document says that understanding the causes of PCOS is important for treatment, especially in distinguishing the syndrome from just having cystic ovaries, and that losing weight is key for obese women with PCOS.

Polycystic Ovary Syndrome can cause hair loss and skin issues, and early treatment is important for preventing complications.

The combination therapy improved PCOS symptoms in both obese and non-obese women, with weight loss in the obese group.

Different anti-androgen medications can help treat excessive hair growth, but the right choice depends on accurate diagnosis.

An mFG score of 7 or higher indicates hirsutism in Filipino women, often linked to higher free testosterone levels.

Chromium supplements don't improve insulin, hormone levels, or cholesterol in women with PCOS but raise testosterone levels.

Cross-sex hormone therapy is important for managing gender dysphoria and requires careful monitoring and healthcare provider education.

Antiandrogen therapies are beneficial for treating skin and hair conditions related to androgen levels.